(5alpha)-17-hydroxy-11,20-dioxopregnan-3-yl acetate

(5Z)-5-(3,4-dimethoxybenzylidene)-2,4-imidazolidinedione

(7R,8R)-tricyclo[4.2.2.0(2,5)]dec-9-ene-7,8-dicarboxylic acid

(Cyclohexylmethyl)magnesium bromide solution

(环己基甲基)溴化镁

(nonylamino)acetic acid hydrochloride

(R)-Xyl-SDP(O)

[(1R)-7′-[Bis(3,5-dimethylphenyl)phosphino]-2,2′,3,3′-tetrahydro-1,1′-spirobi[1H-inden]-7-yl]bis(3,5-dimethylphenyl)phosphine oxide

(S,R,S)-AHPC-PEG1-azide

(S,R,S)-AHPC-PEG₃-azide

(S,R,S)-AHPC-PEG₆-butyl azide

(S,R,S)-VL285 Phenol-PEG₁-piperazine hydrochloride

(S)-2-Phenyl-5-(pyrrolidin-2-yl)-1,3,4-oxadiazole hydrochloride

(S)-Xyl-SDP

(S)-(-)-7,7′-Bis[di(3,5-dimethylphenyl)phosphino]-2,2′,3,3′-tetrahydro-1,1′-spirobiindene

1-[(2-aminoethyl)amino]-3-(isopentyloxy)-2-propanol

1-[(2,2-diphenyl-1,3-dioxolan-4-yl)methyl]-4-(4-fluorophenoxy)-1,2,3,6-tetrahydropyridine oxalate

1-[(4-methoxyphenyl)(phenyl)methyl]piperazine